Clinical Trials Increase Off-Study Drug Use: A Segmented Time-Series Analysis.
Guillaume Butler-LaporteMatthew Pellan ChengDaniel J G ThirionSamuel De L'Étoile-MorelCharles FrenetteKatryn PaquetteAlexander LawandiEmily G McDonaldTodd C LeePublished in: Open forum infectious diseases (2020)
Despite the DASH trial being a negative study, it impacted the prescribing habits of local clinicians during recruitment. Trialists should be aware of potential off-target study effects, and prescribers should be wary of early uptake of interventions before definitive study results.